Emadine Eye Drops 5Ml

Brand : alcon pharma

Rs. 690.65

Rs. 727.00

|

QUICK DELIVERY

Emadine Eye Specification

Requires Prescription (YES/NO)

Yes

Generics

Emedastine Difumarate

Used For

Eye Infection

How it works

Emedastine is a relatively selective, histamine H1 antagonist. In vitro examinations of emedastine’s affinity for histamine receptors (H1: Ki=1.3 nM, H2: Ki=49,067 nM, and H3: Ki=12,430 nM) demonstrate relative selectivity for the H1 histamine receptor. In vivo studies have shown concentration-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Emedastine appears to be devoid of effects on adrenergic, dopaminergic and serotonin receptors.

Emadine Eye Usage And Safety

Dosage

Emedastine Difumarate

Side Effects

Abnormal dreams, asthenia, bad taste, blurred vision, burning or stinging, corneal infiltrates, corneal staining, dermatitis, discomfort, dry eye, foreign body sensation, hyperemia, keratitis, pruritus, rhinitis, sinusitis, and tearing.

Drug Interactions

Ask your physician or pharmacist for dose interactions.

Indication

It is indicated for the temporary relief of the signs and symptoms of allergic conjunctivitis.

When not to Use

It is contraindicated in persons with a known hypersensitivity to emedastine difumarate or any of components.

Emadine Eye Precautions

Precaution

To prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep the bottle tightly closed when not in use. Do not use if the solution has become discolored.

Emadine Eye Warnings

Warning 1

Patients should be advised not to wear a contact lens if their eye is red. Emedastine difumarate ophthalmic solution should not be used to treat contact lens related irritation. The preservative in emedastine difumarate ophthalmic solution) , benzalkonium chloride, may be absorbed by soft contact lenses.

Warning 2

For ophthalmic use only. Not for injection or oral use.

Warning 3

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.